Vector Labs and Absolute Biotech Merge
The union of Vector Laboratories and Absolute Biotech, facilitated by Thompson Street Capital Partners, is a strategic move that...
The union of Vector Laboratories and Absolute Biotech, facilitated by Thompson Street Capital Partners, is a strategic move that...
Viridian Therapeutics plans to initiate two phase 3 clinical trials (REVEAL-1 and REVEAL-2) for VRDN-003, an anti-IGF-1R antibody, in...
A recent study presented at the Cure SMA Research & Clinical Care Meeting has revealed the sustained efficacy and...
Repare Therapeutics, a precision oncology company, has initiated patient dosing in the expanded phase of its TRESR clinical trial,...
The US Food and Drug Administration (FDA) has given its approval to AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) for...
Calidi Biotherapeutics, a biotechnology company focused on developing anti-tumor virotherapies, has forged a partnership with SIGA Technologies to advance...
AstraZeneca has filed and received Priority Review status in the United States for TAGRISSO® (osimertinib) for treating adult patients...
The U.S. Food and Drug Administration (FDA) has approved Almirall’s expanded use of Klisyri for actinic keratosis (AK) treatment....
Nucleus RadioPharma has expanded its capabilities with a Series A investment extension and the appointment of Dr. Tyrell Rivers...
Twist Bioscience has unveiled TB206-001, an antibody antagonist targeting the adenosine A2A receptor (A2AR). This discovery represents a significant...